Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more

White Paper: Value Dossiers for Medical Technologies: What, When and How?

Get insights from MTRC White Papers to discover how value dossiers drive market access, reimbursement success, and strategic differentiation in MedTech

Request free of charge
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: Real-world evidence bridging clinical trials and routine clinical practice to improve patient care

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. 

In a recent publication, D'Souza et al. examined the role of real-world evidence (RWE) in bridging clinical trials and routine clinical practice. They focused on methodological challenges, emerging analytical approaches, and the value of RWE for healthcare decision-making. The authors highlighted that rigorous study design, transparent reporting, robust protocols, and appropriate scientific oversight are essential for generating reliable RWE. Artificial intelligence may improve data quality, scalability, and reproducibility, but it should remain a supportive rather than autonomous tool. These approaches could strengthen the use of RWE in clinical, regulatory, payer, and healthcare resource-allocation decisions.

Access the full-text article here.